Cryo-Cell International, Inc. (CCEL)

NYSEAMERICAN: CCEL · IEX Real-Time Price · USD
3.99
-0.02 (-0.50%)
Feb 7, 2023, 3:59 PM EST - Market closed
-0.5%
Market Cap 33.99M
Revenue (ttm) 29.89M
Net Income (ttm) 1.30M
Shares Out 8.52M
EPS (ttm) 0.15
PE Ratio 26.60
Forward PE n/a
Dividend $0.90 (22.56%)
Ex-Dividend Date Sep 1, 2022
Volume 1,387
Open 4.02
Previous Close 4.01
Day's Range 3.99 - 4.02
52-Week Range 3.99 - 9.55
Beta 0.38
Analysts Buy
Price Target 12.24 (+206.77%)
Earnings Date Feb 28, 2023

About CCEL

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technolo... [Read more]

Sector Healthcare
IPO Date Jan 21, 1997
Employees 83
Stock Exchange NYSEAMERICAN
Ticker Symbol CCEL
Full Company Profile

Financial Performance

In 2021, CCEL's revenue was $28.88 million, a decrease of -7.26% compared to the previous year's $31.15 million. Earnings were $2.08 million, a decrease of -42.52%.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for CCEL stock is "Buy." The 12-month stock price forecast is $12.24, which is an increase of 206.77% from the latest price.

Price Target
$12.24
(206.77% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results

OLDSMAR, Fla., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem ce...

4 months ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend

OLDSMAR, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”), the world's first private cord blood bank to separate and store ste...

6 months ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange

OLDSMAR, Fla., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”, the “Company”), the world's first private cord blood bank to separat...

6 months ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results

OLDSMAR, Fla., July 11, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

7 months ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results

OLDSMAR, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...

10 months ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service

OLDSMAR, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ...

11 months ago - GlobeNewsWire

Cryo-Cell Shares Its 2021 Annual Letter to Shareholders

OLDSMAR, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ...

11 months ago - GlobeNewsWire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021

OLDSMAR, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

1 year ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials

OLDSMAR, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

1 year ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results

OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

1 year ago - GlobeNewsWire

Cryo-Cell International Announces Changes To Its Board of Directors

MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark Portnoy...

1 year ago - GlobeNewsWire

Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market

Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company's Common Stock Has Been Approved For Listing On The Na...

1 year ago - GlobeNewsWire

Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies

Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area.

1 year ago - GlobeNewsWire

Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021

Oldsmar, Florida--(Newsfile Corp. - August 11, 2021) - Cryo-Cell International (OTC Pink: CCEL) today announced that David Portnoy, Chairman of the board and Co-CEO will be attending the Q3 Virtual In...

1 year ago - Newsfile Corp

Cryo-Cell International to Present at the Q3 Virtual Investor Summit

MIAMI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International announces that Chairman of the Board and Co-CEO, David Portnoy, will be presenting at the Q3 Virtual Investor Summit on August 18 th , ...

1 year ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results

OLDSMAR, Fla., July 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem...

1 year ago - GlobeNewsWire

Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials

MIAMI, May 10, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell's Medical Director, Dr. Joanne Kurtzberg and her research team at The Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine are...

1 year ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2021 Financial Results

OLDSMAR, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...

1 year ago - GlobeNewsWire